On February 11, 2020, the test was registered by the Federal Health Surveillance Service. On March 12, 2020, it was announced that Mayo Clinic had developed a test to detect COVID-19 infection. On March 13, 2020, Roche Diagnostics received FDA clearance for a test that could be performed in large quantities in 3.5 hours, allowing one device to perform approximately 4,128 tests in 24 hours.
Tarehe 11 Februari 2020 kipimo kilisajiliwa na Huduma ya Ufuatilia wa Matibabu ya Shirikisho.Tarehe 12 Machi 2020, Kliniki ya Mayo iliripotiwa kuunda kipimo cha kugundua maambukizi ya COVID-19 .Tarehe 13 Machi 2020, Roche Diagnostics ilipokea idhinisho kutoka FDA kwa kipimo ambacho kingefanywa ndani ya saa 3.5 kwa juzuu ya juu, hivyo kuruhusu mashine moja kufanya takriban vipimo 4,128 kwa muda wa saa 24.